<DOC>
	<DOCNO>NCT01744444</DOCNO>
	<brief_summary>Different treatment trial publish acquire nystagmus last decade ; gabapentin memantine find efficient treat pendular nystagmus Multiple Sclerosis . The effect treatment measure nystagmus velocity , amplitude , frequency visual acuity . None trial measure functional visual score oscillopsia score . The aim study evaluate effect gabapentin memantine mean velocity , amplitude frequency pendular nystagmus , well oscillopsia , visual acuity vision-specific health-related quality life score , 10 patient multiple sclerosis . The primary object find best variable evaluate efficiency nystagmus treatment secondary , compare efficiency gabapentin memantine common population patient .</brief_summary>
	<brief_title>Treatment Pendular Nystagmus With Gabapentin Memantine Patients With Multiple Sclerosis</brief_title>
	<detailed_description />
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Multiple Sclerosis</mesh_term>
	<mesh_term>Nystagmus , Pathologic</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<mesh_term>gamma-Aminobutyric Acid</mesh_term>
	<criteria>All patient may clinically definite , laboratorysupported diagnosis multiple sclerosis accord Mac Donald criterion . All patient may present chronic acquire pendular nystagmus due MS , observe period 6 month . All patient inform design purpose study , give inform , write consent protocol , may approve local ethic committee . Age : 18 Able understand instruction Having health coverage Able sit 1 hour Stable dosage previous medication ( begin 3 week previously terminate end trial duration ) , except steroid , gabapentin memantine . Ophthalmological Other ophthalmological disorder could impair correct visual acuity ( Maculopathy , Retinopathyâ€¦ ) Neurological Ongoing seizure Severe handicap allow sit position 1 hour Suicidal behavior risk Treatment Under memantine gabapentin medication ( medication stop least 1 week gabapentin 3 week memantine ) Under morphine , NmethylDaspartate amantadine , ketamine dextromethorphan Steroid medication current relapse ( begin 3 week previously terminate end trial duration ) Known hypersensitivity memantine gabapentin General Unstable medical state Patient galactose intolerance , lapp lactase deficiency glucosegalactose malabsorption Moderate renal failure ( creatinine clearance &lt; 50 mL/min bioassay date less one month ) Recent heart infarction ( &lt; 3months ) Unstable congestive heart insufficiency Unstable arterial hypertension Leucopenia ( &lt; 2500/mm3 ) Transaminase increase ( &gt; 5 time normal value ) Pregnancy ( question ) Tutelage legal protection measure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>